924 related articles for article (PubMed ID: 18202440)
21. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
Ashida H; Sasakawa C
Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
[TBL] [Abstract][Full Text] [Related]
22. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection.
Kobayashi T; Ogawa M; Sanada T; Mimuro H; Kim M; Ashida H; Akakura R; Yoshida M; Kawalec M; Reichhart JM; Mizushima T; Sasakawa C
Cell Host Microbe; 2013 May; 13(5):570-583. PubMed ID: 23684308
[TBL] [Abstract][Full Text] [Related]
23. The type three secretion system effector protein IpgB1 promotes Shigella flexneri cell-to-cell spread through double-membrane vacuole escape.
Weddle EA; Köseoğlu VK; DeVasure BA; Agaisse HF
PLoS Pathog; 2022 Feb; 18(2):e1010380. PubMed ID: 35202448
[TBL] [Abstract][Full Text] [Related]
24. A Brief History of
Lampel KA; Formal SB; Maurelli AT
EcoSal Plus; 2018 Jan; 8(1):. PubMed ID: 29318984
[TBL] [Abstract][Full Text] [Related]
25. Shigella flexneri regulation of ARF6 activation during bacterial entry via an IpgD-mediated positive feedback loop.
Garza-Mayers AC; Miller KA; Russo BC; Nagda DV; Goldberg MB
mBio; 2015 Mar; 6(2):e02584. PubMed ID: 25736891
[TBL] [Abstract][Full Text] [Related]
26. IcsA is a Shigella flexneri adhesin regulated by the type III secretion system and required for pathogenesis.
Brotcke Zumsteg A; Goosmann C; Brinkmann V; Morona R; Zychlinsky A
Cell Host Microbe; 2014 Apr; 15(4):435-45. PubMed ID: 24721572
[TBL] [Abstract][Full Text] [Related]
27. The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulence.
Barnoy S; Gancz H; Zhu Y; Honnold CL; Zurawski DV; Venkatesan MM
Gut Microbes; 2017 Jul; 8(4):335-350. PubMed ID: 28277944
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen.
Lucchini S; Liu H; Jin Q; Hinton JC; Yu J
Infect Immun; 2005 Jan; 73(1):88-102. PubMed ID: 15618144
[TBL] [Abstract][Full Text] [Related]
29. The
Wood TE; Westervelt KA; Yoon JM; Eshleman HD; Levy R; Burnes H; Slade DJ; Lesser CF; Goldberg MB
mBio; 2022 Jun; 13(3):e0127022. PubMed ID: 35638611
[TBL] [Abstract][Full Text] [Related]
30. The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.
Faherty CS; Wu T; Morris CR; Grassel CL; Rasko DA; Harper JM; Shea-Donohue T; Fasano A; Barry EM
Gut Microbes; 2016 Nov; 7(6):486-502. PubMed ID: 27657187
[TBL] [Abstract][Full Text] [Related]
31. The regulatory protein PhoP controls susceptibility to the host inflammatory response in Shigella flexneri.
Moss JE; Fisher PE; Vick B; Groisman EA; Zychlinsky A
Cell Microbiol; 2000 Dec; 2(6):443-52. PubMed ID: 11207599
[TBL] [Abstract][Full Text] [Related]
32. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis.
Fernandez MI; Sansonetti PJ
Int J Med Microbiol; 2003 Apr; 293(1):55-67. PubMed ID: 12755366
[TBL] [Abstract][Full Text] [Related]
33. Macrophage Apoptosis Triggered by IpaD from Shigella flexneri.
Arizmendi O; Picking WD; Picking WL
Infect Immun; 2016 Jun; 84(6):1857-1865. PubMed ID: 27068089
[TBL] [Abstract][Full Text] [Related]
34. ATP-mediated Erk1/2 activation stimulates bacterial capture by filopodia, which precedes Shigella invasion of epithelial cells.
Romero S; Grompone G; Carayol N; Mounier J; Guadagnini S; Prevost MC; Sansonetti PJ; Van Nhieu GT
Cell Host Microbe; 2011 Jun; 9(6):508-19. PubMed ID: 21669399
[TBL] [Abstract][Full Text] [Related]
35. Shigella flexneri T3SS effector IpaH4.5 modulates the host inflammatory response via interaction with NF-κB p65 protein.
Wang F; Jiang Z; Li Y; He X; Zhao J; Yang X; Zhu L; Yin Z; Li X; Wang X; Liu W; Shang W; Yang Z; Wang S; Zhen Q; Zhang Z; Yu Y; Zhong H; Ye Q; Huang L; Yuan J
Cell Microbiol; 2013 Mar; 15(3):474-85. PubMed ID: 23083102
[TBL] [Abstract][Full Text] [Related]
36. The MFS efflux pump EmrKY contributes to the survival of Shigella within macrophages.
Pasqua M; Grossi M; Scinicariello S; Aussel L; Barras F; Colonna B; Prosseda G
Sci Rep; 2019 Feb; 9(1):2906. PubMed ID: 30814604
[TBL] [Abstract][Full Text] [Related]
37. Expression of bacterial virulence factors and cytokines during in vitro macrophage infection by enteroinvasive Escherichia coli and Shigella flexneri: a comparative study.
Bando SY; Moreno AC; Albuquerque JA; Amhaz JM; Moreira-Filho CA; Martinez MB
Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):786-91. PubMed ID: 20944993
[TBL] [Abstract][Full Text] [Related]
38. Human Enteric Defensin 5 Promotes
Xu D; Liao C; Xiao J; Fang K; Zhang W; Yuan W; Lu W
Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31611271
[TBL] [Abstract][Full Text] [Related]
39. Shigella type III secretion effectors: how, where, when, for what purposes?
Parsot C
Curr Opin Microbiol; 2009 Feb; 12(1):110-6. PubMed ID: 19157960
[TBL] [Abstract][Full Text] [Related]
40. The Shigella type three secretion system effector OspF invades host nucleus by binding host importin α1.
Zhao H; Zhang Y; Wu P; Wang J; Li H
World J Microbiol Biotechnol; 2019 Apr; 35(5):71. PubMed ID: 31011826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
